SomaLogic, Inc. is a revolutionary life sciences company based in Boulder, CO that is dedicated to understanding the human proteome and transforming healthcare. Their global platform, the SomaScan Assay Services, allows for the measurement of 11,000 proteins from a small sample size, providing high sensitivity, specificity, and reproducibility. With their expertise in aptamer-based proteomics, SomaLogic offers a wide range of services and solutions for various therapeutic areas, including cardiovascular disease, neurology, COVID-19, diabetes, NASH, rare diseases, and cancer.
Through their pioneering technology and extensive research, SomaLogic has gained recognition with numerous peer-reviewed publications, patents, and proteomic measurements. Their platform enables scientists and researchers to move from discovery to validation efficiently, making it a valuable tool for academic medical centers, pharmaceutical companies, biotechnology firms, and contract research organizations. With a focus on providing targeted insights and better decision-making, SomaLogic is revolutionizing the field of proteomics and its applications in understanding human health and disease.
Generated from the website